Warner - Lambert up on FDA OK , drug sector rallies . Warner - Lambert Co shares jumped on Wednesday amid a broader rally by drug stocks and after Warner - Lambert won U . S . Food and Drug Administration approval to market a cholesterol - cutting drug . Warner shares jumped two to 76 - 1 / 4 . Warner said the drug Lipitor has been shown to cut elevated LDL - cholestoerol and is the only drug in its class specifically indicated for cutting both elevated LDL - cholesterol and triglycerides in patients with high levels of cholesterol . A broad surge in stocks of pharmaceutical companies after a bullish earnings forecast by industry leader Merck and Co Inc also benefitted Warner - Lambert . The Standard & Poor ' s pharmaceuticals index rose 3 . 36 , or 1 . 75 percent , to 194 . 95 after Merck said it expected strong profits in the fourth quarter of 1996 and for all of 1997 . Merck shares rose 1 - 3 / 4 to 78 in heavy trading . Pfizer Inc shares added 1 - 3 / 4 to 82 - 3 / 8 , Johnson & Johnson shares rose 1 - 1 / 4 to 49 - 3 / 4 , and Schering - Plough Corp added 7 / 8 to 64 - 7 / 8 . 
